<DOC>
	<DOCNO>NCT00704535</DOCNO>
	<brief_summary>The purpose study evaluate overall safety , tolerability , efficacy Ezetimibe use alone combination statin patient hypercholesterolemia</brief_summary>
	<brief_title>Evaluation Safety , Tolerability Efficacy Ezetimibe Select Population Filipinos With Hypercholesterolemia ( Study P04748 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Outpatient men woman , age 18 year . Patients primary ( heterozygous familial nonfamilial ) hypercholesterolemia homozygous familial hypercholesterolemia . Known hypersensitivity Ezetimibe . Moderate severe hepatic insufficiency . Persistent elevation serum transaminase level 1.5 time upper limit normal . Pregnancy lactation . Concomitant intake bile acid sequestrants ( resin ) , nicotinic acid ( niacin ) , fibric acid ( fibrates ) , cyclosporine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>